home / stock / bctx / bctx news

BCTX News and Press, BriaCell Therapeutics Corp. From 08/19/21

Stock Information
Company Name: BriaCell Therapeutics Corp.
Stock Symbol: BCTX
Market: NASDAQ
Website: briacell.com
Menu
BCTX BCTX Quote BCTX Short BCTX News BCTX Articles BCTX Message Board
Get BCTX Alerts

News, Short Squeeze, Breakout and More Instantly...
BCTX - BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer

NEW YORK and VANCOUVER, British Columbia and LOS ANGELES, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“ BriaCell ” or the “ Company ”), a clinical-stage biotechnology company specializing in targeted im...
BCTX - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com But hold on just a second. ...

BCTX - Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virt...

BCTX - BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX.V: BCT) Featured in Coverage of Investor Summit Group's Q3 Virtual Event

BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX-V:BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer.  BriaCell achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast...
BCTX - BriaCell/Incyte opens enrollment for Phase I/IIa combo study in breast cancer

BriaCell Therapeutics (BCTX) announces the open recruitment and enrollment of their collaborative clinical study with Incyte (INCY).The Phase I/IIa combination study is designed to evaluate BriaCell’s lead candidate, Bria-IMT, with Incyte’s checkpoint inhibitor, retifanlimab, an...

BCTX - BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for Enrollment

NEW YORK and VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies for advan...

BCTX - BriaCell to Present at Three Upcoming Investor Conferences

BERKELEY, Calif. and VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies f...
BCTX - 50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13 th - 15 th , 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meeti...

BCTX - Osmotica Pharmaceuticals, Star Equity leads healthcare gainers; Theravance Biopharma, Corbus Pharmaceuticals among major losers

Gainers: Osmotica Pharmaceuticals (OSMT) +38%, Star Equity (STRR) +16%, Atossa Therapeutics (ATOS) +15%, Vor Biopharma (VOR) +12%, Rezolute (RZLT) +10%.Losers: Theravance Biopharma (TBPH) -8%, Corbus Pharmaceuticals (CRBP) -8%, Kaleido Bi...

BCTX - Midatech Pharma, Cellect Biotechnology leads healthcare gainers; CureVac, Novan among major losers

Gainers: Midatech Pharma (MTP) +37%, Cellect Biotechnology (APOP) +30%, Synaptogenix (SNPX) +24%, Clearside Biomedical (CLSD) +16%, Tiziana Life Sciences (TLSA) +16%.Losers: CureVac (CVAC) -44%, Novan (NOVN) -19%, Prothena (PRTA) -14...
Previous 10 Next 10